ANDREW LAVEAR: Open Payments
NPI 1336643543 · FT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,522 in 179 payments from 20 companies in 2025. Trend: 2023 $1,575 · 2024 $3,588 · 2025 $8,522
Speaker / faculty: $4,575Food & beverage: $3,272Consulting: $675
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 38 | $5,895 |
| ABBVIE INC. | 59 | $880 |
| UCB, Inc. | 11 | $289 |
| Lundbeck LLC | 13 | $261 |
| Lilly USA, LLC | 5 | $203 |
| Teva Pharmaceuticals USA, Inc. | 15 | $202 |
| Eisai Inc. | 6 | $164 |
| Neurelis, Inc. | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $88 |
| Biogen, Inc. | 4 | $82 |
Products named: NURTEC ODT, QULIPTA, VYEPTI, Leqembi, UBRELVY, Fintepla, BOTOX, AJOVY.
Industry payments across TX — which companies pay providers there.
